Dr. Jeffrey Holter Dunn, M.D. Dermatology Medicare: Medicare Enrolled Practice Location: 559 Vincent St, Attn: 302 Asts, Peterson Afb, CO 80914 Phone: 719-556-1132 Fax: 719-556-1129 |
News Archive
CEL-SCI Corporation announced today that it has commenced its Phase III clinical trial for Multikine®, the Company's flagship immunotherapy, at the National Institute of Oncology in Budapest, Hungary. Enrollment is expected to start soon in this center. The study is already ongoing at twelve clinical sites in the United States, Canada, Poland and India.
Researchers at the New York University Grossman School of Medicine and Biohaven Pharmaceuticals found that the REGN10933 and REGN10987 combination was 9.1-fold less potent on the B.1.351 variant, which emerged in South Africa, and 16.2-fold less potent on mink cluster 5.
GE Healthcare today announced that it has agreed to acquire certain Mammography assets of Rayence, a subsidiary of Vatech Co Ltd, a Korean X-Ray manufacturer. The Mammography assets of Rayence will, at closing, become part of the Detection & Guidance Solutions business unit of GE Healthcare.
A new study shows that carotid artery stenting (CAS) following prior same-side carotid artery revascularization is safe, effective and results in lower incidences of in-hospital death, stroke and heart attack compared to first-time CAS for carotid artery stenosis.
Many cardiac implantable electronic device models currently in use were approved via a Food and Drug Administration review process in which the models were assumed safe and effective based on approval of prior versions of the device, according to a study in the January 22/29 issue of JAMA.
› Verified 3 days ago